右丙亚胺与儿童霍奇金病继发恶性肿瘤的关联风险：一项缺乏确凿证据的说法。 - Suppr

Suppr

超能文献

Dexrazoxane-associated risk for secondary malignancies in pediatric Hodgkin's disease: a claim without compelling evidence.

作者信息

Lipshultz Steven E, Lipsitz Stuart R, Orav Endel John

出版信息

J Clin Oncol. 2007 Jul 20;25(21):3179; author reply 3180. doi: 10.1200/JCO.2007.11.8778.

DOI:10.1200/JCO.2007.11.8778

PMID:17634500

Abstract

摘要

相似文献

Dexrazoxane-associated risk for secondary malignancies in pediatric Hodgkin's disease: a claim without compelling evidence.右丙亚胺与儿童霍奇金病继发恶性肿瘤的关联风险：一项缺乏确凿证据的说法。

J Clin Oncol. 2007 Jul 20;25(21):3179; author reply 3180. doi: 10.1200/JCO.2007.11.8778.

Dexrazoxane-associated risk for acute myeloid leukemia/myelodysplastic syndrome and other secondary malignancies in pediatric Hodgkin's disease.右丙亚胺与儿童霍奇金病患者急性髓系白血病/骨髓增生异常综合征及其他继发性恶性肿瘤的相关性风险

J Clin Oncol. 2007 Feb 10;25(5):493-500. doi: 10.1200/JCO.2005.02.3879.

Absence of secondary malignant neoplasms in children with high-risk acute lymphoblastic leukemia treated with dexrazoxane.接受右丙亚胺治疗的高危急性淋巴细胞白血病儿童未发生继发性恶性肿瘤。

J Clin Oncol. 2008 Mar 1;26(7):1106-11. doi: 10.1200/JCO.2007.12.2481.

Dexrazoxane-associated risk for secondary malignancies in pediatric Hodgkin's disease: a claim without evidence.右丙亚胺与儿童霍奇金淋巴瘤继发恶性肿瘤的相关性风险：毫无证据的说法。

J Clin Oncol. 2007 Oct 10;25(29):4689-90; author reply 4690-1. doi: 10.1200/JCO.2007.12.6888.

Secondary malignancies after treatment for indolent non-Hodgkin's lymphoma: a 16-year follow-up study.惰性非霍奇金淋巴瘤治疗后的继发性恶性肿瘤：一项16年的随访研究

Haematologica. 2008 Mar;93(3):398-404. doi: 10.3324/haematol.12120. Epub 2008 Feb 11.

Secondary malignancies after therapy of indolent non-Hodgkin's lymphoma.惰性非霍奇金淋巴瘤治疗后的继发性恶性肿瘤

Haematologica. 2008 Mar;93(3):336-8. doi: 10.3324/haematol.12585.

Do children have increased susceptibility for developing secondary acute myelogenous leukemia?儿童患继发性急性髓系白血病的易感性会增加吗？

Chem Biol Interact. 2005 May 30;153-154:223-9. doi: 10.1016/j.cbi.2005.03.026.

[Secondary malignancies after successful primary treatment of malignant Hodgkin's lymphoma].[恶性霍奇金淋巴瘤初次治疗成功后的继发性恶性肿瘤]

Pathologe. 2006 Feb;27(1):47-52. doi: 10.1007/s00292-005-0811-0.

New therapies in Hodgkin's lymphoma.霍奇金淋巴瘤的新疗法。

Clin Adv Hematol Oncol. 2004 Feb;2(2):80, 83.

Myelodysplastic syndrome and acute myeloid leukemia after treatment with fludarabine, mitoxantrone, and dexamethasone.氟达拉滨、米托蒽醌和地塞米松治疗后发生的骨髓增生异常综合征和急性髓系白血病。

Am J Hematol. 2006 Jun;81(6):471-3. doi: 10.1002/ajh.20599.

引用本文的文献

Cardiovascular toxicity of breast cancer treatments: from understanding to enhancing survivorship care.乳腺癌治疗的心血管毒性：从认识到加强生存护理

ESMO Open. 2025 Jun 2;10(6):105128. doi: 10.1016/j.esmoop.2025.105128.

Dexrazoxane makes doxorubicin-induced heart failure a rare event in sarcoma patients receiving high cumulative doses.右丙亚胺使接受高累积剂量多柔比星的肉瘤患者发生多柔比星诱导的心力衰竭成为罕见事件。

Cardiooncology. 2025 Mar 19;11(1):29. doi: 10.1186/s40959-025-00323-8.

Cardiotoxicity: A Major Setback in Childhood Leukemia Treatment.心脏毒性：儿童白血病治疗的重大挫折。

Dis Markers. 2021 Jan 6;2021:8828410. doi: 10.1155/2021/8828410. eCollection 2021.

Dexrazoxane for cardioprotection in older adults with acute myeloid leukemia.右丙亚胺对老年急性髓系白血病患者的心脏保护作用

Leuk Res Rep. 2017 Apr 14;7:36-39. doi: 10.1016/j.lrr.2017.04.001. eCollection 2017.

Prevention of cardiotoxicity among survivors of childhood cancer.儿童癌症幸存者心脏毒性的预防

Br J Clin Pharmacol. 2017 Mar;83(3):455-465. doi: 10.1111/bcp.13120. Epub 2016 Oct 12.

Effect of Remote Ischaemic Conditioning in Oncology Patients Undergoing Chemotherapy: Rationale and Design of the ERIC-ONC Study--A Single-Center, Blinded, Randomized Controlled Trial.远程缺血预处理对接受化疗的肿瘤患者的影响：ERIC-ONC研究的原理与设计——一项单中心、盲法、随机对照试验

Clin Cardiol. 2016 Feb;39(2):72-82. doi: 10.1002/clc.22507. Epub 2016 Jan 25.

Cardiovascular disease in adult survivors of childhood cancer.儿童癌症成年幸存者中的心血管疾病

Annu Rev Med. 2015;66:161-76. doi: 10.1146/annurev-med-070213-054849.

Nat Rev Clin Oncol. 2013 Dec;10(12):697-710. doi: 10.1038/nrclinonc.2013.195. Epub 2013 Oct 29.

Cardiovascular effects in childhood cancer survivors treated with anthracyclines.蒽环类药物治疗的儿童癌症幸存者的心血管效应。

Cardiol Res Pract. 2011 Feb 10;2011:134679. doi: 10.4061/2011/134679.

Assessment of dexrazoxane as a cardioprotectant in doxorubicin-treated children with high-risk acute lymphoblastic leukaemia: long-term follow-up of a prospective, randomised, multicentre trial.评价右雷佐生在接受多柔比星治疗的高危急性淋巴细胞白血病患儿中的心脏保护作用：一项前瞻性、随机、多中心试验的长期随访。

Lancet Oncol. 2010 Oct;11(10):950-61. doi: 10.1016/S1470-2045(10)70204-7. Epub 2010 Sep 16.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验